Uncategorised - European Medical Journal

Malaria In Pregnancy Drives Maternal Anaemia Burden

Modelling across seven African countries shows malaria in pregnancy remains a major cause of maternal anaemia, with over 2 million cases projected in 2023.

Fasting Mimetic Improves Cardiometabolic Health

Mimio reduced total cholesterol, LDL cholesterol, LDL particle number, oxidised LDL, non-HDL cholesterol, and fasting glucose.

Untreated Sleep Apnoea: A Hidden Multi-Billion Hit to Productivity

Obstructive sleep apnoea may affect 1 in 5 adults in the UK and USA, costing billions in lost productivity, but can be offset by effective treatment.

Photonic Sensor Improves Cervical Cancer Detection

A temperature tested photonic crystal sensor achieves over 91% accuracy in cervical cancer screening using label free optical detection.

Targeting Hidden HIV Reservoir Clones for Future Cure Strategies

Study dissects HIV reservoir clones that persist on ART, revealing how CD8+ T cells and resistance pathways could be harnessed for future cure strategies.

HBV

USA Newborn Hepatitis B Vaccination Rates Dive

HBV vaccination rates among infants in the USA have fallen by more than 10 percentage points in the past two years.

Surgeon and oncology clinician reviewing a cardiac surgery plan for a patient with cancer after cardiac surgery

Cancer After Cardiac Surgery Linked to Shorter Survival

Cancer after cardiac surgery was tied to shorter long-term survival, even though in-hospital mortality remained low.

thyroid cancer

Thyroid Cancer Overdiagnosis at Up to 94% in Past Decades

An estimated 72% to 94% of cases were overdiagnosed in the USA between 1991 and 2019, according to a 2026 study.

Former American football player with cognitive and neuropsychiatric function concept

Cognitive and Neuropsychiatric Function in Former Football Players

Former American football players showed poorer cognitive and neuropsychiatric function, with symptoms worsening by exposure level.

weight loss

Swallowable Gastric Balloon Approved for Weight Loss

At 48 weeks, 58% of participants in the treatment group lost more than 5% of their total body weight, meeting the responder rate co-primary endpoint.